Pregnancy: Safe if indicated.
Meningococcal ACWY conjugate vaccines are non-live and considered safe during pregnancy.
Recommended for pregnant travelers requiring vaccination for Hajj/Umrah (Saudi Arabia requirement).
Limited formal pregnancy studies, but extensive post-marketing experience without safety signals.
ACIP: "MenACWY may be administered during pregnancy if indicated."
Breastfeeding: Safe — no restrictions.
Meningococcal ACWY conjugate vaccines are inactivated and safe during breastfeeding. No modification to breastfeeding schedule required.
Pediatric use:
Menveo: licensed from 2 months of age. Infants: multi-dose series.
Nimenrix: licensed from 6 weeks of age.
MenQuadfi: licensed from 12 months of age.
Routine adolescent vaccination (11–12 years) with booster at 16 years (US ACIP).
Children with asplenia, complement deficiency, or HIV: 2-dose primary series + boosters every 3–5 years.
MenB vaccines (Bexsero, Trumenba) for serogroup B: separate schedule.
Geriatric use:
No specific age-related contraindications. Standard single-dose schedule applies.
Elderly travelers to the African meningitis belt or performing Hajj should receive MenACWY.
Immune response adequate in healthy elderly adults.
Asplenic elderly patients: 2-dose series + boosters every 5 years.
| Allura | Alama | Kwanaki daga na baya | Kewayon shekaru |
|---|---|---|---|
| Allura 1 | MenQuadfi | — | 1 shekaru+ |
Kun san allurar rigakafin da kuke bukata? Da kyau. Ba ku sani ba? Ku gaya mana inda kuke tafiya — za mu nemo allurar da ta dace da asibiti. Kyauta, ba tare da wani hakki ba.
Abun ciki a wannan shafin don bayani da ilimi ne kawai. Ba ya zama shawarar likita, gano cuta, ko shawarwarin magani ba. Idan kuna da damuwar lafiya, tuntuɓi ƙwararren ma’aikacin lafiya. Medova ba mai ba da sabis na likitanci ba ne.
Cikakkun sharuɗɗan amfani